These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3260892)

  • 1. Antibodies to extractable nuclear antigens in psoriasis vulgaris.
    Sehgal S; Kumar B; Kaur S; Datta U; Anand S
    Indian J Med Res; 1988 Mar; 87():270-4. PubMed ID: 3260892
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of antibodies to the extractable nuclear antigens by enzyme linked immunosorbent assay.
    Aziz KA; Faizal AA
    Saudi Med J; 2005 Mar; 26(3):486-8. PubMed ID: 15806228
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical significance of anti-Sm antibody analysis].
    Tojo T; Ogasawara T
    Nihon Rinsho; 1990 Feb; 48 Suppl():497-500. PubMed ID: 2113132
    [No Abstract]   [Full Text] [Related]  

  • 4. Antinuclear antibodies are not induced by PUVA treatment in patients with uncomplicated psoriasis.
    Calzavara-Pinton P; Franceschini F; Rastrelli M; Manera C; Zane C; Cattaneo R; De Panfilis G
    J Am Acad Dermatol; 1994 Jun; 30(6):955-8. PubMed ID: 8188886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
    Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of a multiplex assay compared to enzyme and precipitation methods for anti-ENA testing in systemic lupus and systemic sclerosis.
    Albon S; Bunn C; Swana G; Karim Y
    J Immunol Methods; 2011 Feb; 365(1-2):126-31. PubMed ID: 21184759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of anti-ENA antibody].
    Tojo T
    Nihon Rinsho; 1990 Feb; 48 Suppl():478-81. PubMed ID: 2113130
    [No Abstract]   [Full Text] [Related]  

  • 8. [Detection of autoantibodies to extractable nuclear antigens in autoimmune diseases of rheumatic origin using immunoblotting--comparison with counter-electrophoresis].
    Hiepe F; Kiessig ST; Yamamoto K; Prokop G; Mielke F; Lukowsky A; Schlaak B; Miyamoto T; Apostoloff E
    Z Rheumatol; 1990; 49(5):304-9. PubMed ID: 2080688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to extractable nuclear antigens. Has technological drift affected clinical interpretation?
    Lock RJ; Unsworth DJ
    J Clin Pathol; 2001 Mar; 54(3):187-90. PubMed ID: 11253128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of ELISA for the measurement of autoantibodies to nuclear antigens: comparison with other methodologies.
    Firer MA; Shoenfeld Y; Isenberg DA; Slor H
    Isr J Med Sci; 1988 Dec; 24(12):747-50. PubMed ID: 3147270
    [No Abstract]   [Full Text] [Related]  

  • 11. [Detection and differentiation of autoantibodies to extractable nuclear antigens with immunoenzyme tests].
    Horeschi G; Morenz J; Struy H
    Allerg Immunol (Leipz); 1987; 33(4):203-13. PubMed ID: 2449813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of antibodies to extractable nuclear antigens with counterimmunoelectrophoresis and the Western blot technic].
    Hauke G; Lührmann R; Metz B; Peter HH
    Z Rheumatol; 1988; 47(1):26-9. PubMed ID: 3259356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of IgG subclass antibodies anti-ENA (extractable nuclear antigens) in systemic rheumatic diseases.
    Sánchez Ibarrola A; Valdivieso R; Wong E; Sánchez Arroyo R
    Allergol Immunopathol (Madr); 1987; 15(4):195-200. PubMed ID: 3500626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Demonstration of autoantibodies against extractable nuclear antigens(ENA) in immunoenzyme assay (ELISA) and in transmigratory electrophoresis].
    Kühl R; Sachs V; Töpfer A
    Beitr Infusionther Klin Ernahr; 1987; 18():389-92. PubMed ID: 3326596
    [No Abstract]   [Full Text] [Related]  

  • 15. Counterimmunoelectrophoresis with serum prediffusion: an improved method for the detection and identification of antibodies against extractable nuclear and cytoplasmic antigens.
    Walravens MJ; Vanherrewegen H; Lacquet F; Godefridis G; Korevits G; Stevens E; Marien G; Molenberghs G
    J Immunol Methods; 1997 Feb; 201(1):89-98. PubMed ID: 9032412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay of antinuclear antibodies by ELISA using nuclei as antigen.
    Ara J; Ali R
    Eur J Clin Chem Clin Biochem; 1993 May; 31(5):289-93. PubMed ID: 8357937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibodies against extractable nuclear antigens. Clinico-biological correlations in 100 cases].
    Barbouch MR; Gorgi Y; Ayed K; Haddad S; Ben Ayed H
    Rev Rhum Mal Osteoartic; 1989 Apr; 56(5):389-94. PubMed ID: 2499031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assays for Sm and RNP antibodies: pitfalls and technical considerations.
    Molden DP; Suzuki H; Nakamura RM
    Diagn Immunol; 1985; 3(1):24-8. PubMed ID: 3922661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it useful to test for antibodies to extractable nuclear antigens in the presence of a negative antinuclear antibody on Hep-2 cells?
    Thomson KF; Murphy A; Goodfield MJ; Misbah SA
    J Clin Pathol; 2001 May; 54(5):413. PubMed ID: 11328850
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunologic tests: Anti-Sp100 antibody].
    Mori S; Wake H; Takahashi HK; Nishibori M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():640-2. PubMed ID: 16111356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.